Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytoma

Clinical Endocrinology

Volumn 46, Issue 1, 1997, Pages 39-44

  Kopf, D ^a   Bockisch, A ^b   Steinert, H ^b   Hahn, K ^c   Beyer, J ^b   Neumann, H P H ^d   Hensen, J ^e   Lehnert, H ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; CATECHOLAMINE; CYCLOPHOSPHAMIDE; DACARBAZINE; OCTREOTIDE; PENTETREOTIDE IN 111; VINCRISTINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031015524     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.d01-1738.x     Document Type: Article

References (17)

1. Averbuch, S.D., Steakley, C.S., Young, R.C., Gelmann, E.P., Goldstein, D.S., Stull, R. & Keiser, H.R. (1988) Malignant pheochromocytoma: Effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Annals of Internal Medicine, 109, 267-273.
2. Bravo, E.L. (1994) Evolving concepts in the pathophysiology, diagnosis, and treatment of phaeochromocytoma. Endocrine Reviews, 15, 356-367.
3. Epelbaum, J., Bertherat, J., Prevost, G., Kordon, C., Meyerhof, W., Wulfsen, I., Richter, D. & Plouin, P.F. (1995) Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant phaeochromocytomas. Journal of Clinical Endocrinology and Metabolism, 80, 1837-1844.
4. Görges, R., Cordes, U., Bartelt, K.M., Beyer, J., Schrezenmeir, J. & Bockisch, A. (1995) Correlation between somatostatin receptor scintigraphy and acute GH response to a single octreotide dose (octreotide test) for evaluating the octreotide-responder status in acromegaly. Experimental & Clinical Endocrinology and Diabetes. 103, 87 (Abstract).
5. Kann, P., Lichtwald, K., Ehrengaard, M., Diaz, M., Görges, R. & Beyer, J. (1995) Inhibition der Katecholaminausschüttung benigner adrenaler Phäochromozytome durch Octreotide. In Endokrine Tumoren - Prognostische Parameter, rationelle Diagnostik und Therapie (ed. H. Lehnert, D. Kopf, J. Hensen) pp.203-206. Magdeburg.
6. Lamberts, S.W.J., Krenning, E. & Reubi, J.C. (1991) The role of somatostatin and its analogs in the diagnosis and treatment of tumours. Endocrine Reviews, 12, 450-182.
7. Lamberts, S.W.J., Reubi, J.C. & Krenning, E.P. (1993) Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumours. Acta Oncologica, 32, 167-170.
8. 131 I-MIBG in the diagnosis of metastatic phaeochromocytomas? European Journal of Nuclear Medicine, 20, 933 (abstr.).
9. Nocaudie-Calzada, M., Huglo, D., Deveaux, M., Carnaille, B., Proye, C. & Marchandise, X. (1994) Iodine-123-Tyr-Octreotide uptake in pancreatic tumours and in carcinoids in relation to hormonal inhibition by octreotide. Journal of Nuclear Medicine, 35, 57-62.
10. Norton, J.A., Levin, B. & Jenson, R.T. (1993) Cancer of the endocrine system. In Cancer - Principles and Practice of Oncology. (eds V.T. DeVita, S. Hellmann & S.A. Rosenberg) JB Lippincott Co, Philadelphia.
11. Plouin, P.F., Bertherat, J., Chatellier, G., Billaud, E., Azizi, M., Grouzmann, E. & Epelbaum, J. (1995) Short-term effects of octreotide on blood pressure and plasma catecholamines and neuropeptide Y levels in patients with phaeochromocytoma: a placebo-controlled trial. Clinical Endocrinology, 42, 289-294.
12. Plouin, P.F., Zachareva, S., Bertherat, J., Billaud, E. & Epelbaum, J. (1993) Are phaeochromocytoma somatostatin binding sites functional? American Journal of Hypertension, 6, 60A.
13. Reubi, J.C. & Landolt, A.M. (1989) The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status. Journal of Clinical Endocrinology and Metabolism, 68, 844-850.
14. Reubi, J.C., Waser, B., Khosla, S., Kvols, L., Goellner, R., Krenning, E. and Lamberts, S. (1992) In vitro and in vivo detection of somatostatin receptors in phaeochromocytomas and paragangliomas. Journal of Clinical Endocrinology and Metabolism, 74, 1082-1089.
15. Schlumberger, M., Gicquel, C., & Lumbroso, J. (1992) Malignant phaeochromocytoma: Clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases. Journal of Endocrinological Investigation, 15, 631-42.
16. 111 In-octreotide scintigraphy. European Journal of Nuclear Medicine, 20, 843 (abstract).
17. Tenenbaum, F., Lumbroso, J., Schlumberger, M., Mure, A., Plouin, P.F., Caillou, B. & Parmentier, C. (1995) Comparison of radiolabeled octreotide and metaiodobenzylguanidine (MIBG) scintigraphy in malignant phaeochromocytoma. Journal of Nuclear Medicine, 36, 1-6.